{
  "nctId": "NCT07184398",
  "briefTitle": "Use of a Cysteine-rich Whey Protein Isolate in Post COVID-19 Cognitive Impairment",
  "officialTitle": "Use of a Cysteine-rich Whey Protein Isolate (Immunocal®) in Post COVID-19 Cognitive Impairment",
  "protocolDocument": {
    "nctId": "NCT07184398",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan: Summary table of data statistical analysis",
    "date": "2025-09-15",
    "uploadDate": "2025-09-15T12:49",
    "size": 805542,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT07184398/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "SINGLE",
  "enrollmentInfo": {
    "enrollmentCount": 120,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2024-07-01",
    "completionDate": "2025-01-01",
    "primaryCompletionDate": "2024-09-30",
    "firstSubmitDate": "2025-09-09",
    "firstPostDate": "2025-09-19"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion: - Adults ≥18 years with confirmed prior COVID-19 - with persistent cognitive symptoms - able to complete testing - and willing to consent.\n\nExclusion: - Pre-existing dementia or major psychiatric illness - whey protein allergy - participation in another cognitive trial - severe hepatic/renal/metabolic disease, pregnancy - or any condition interfering with participation.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "70 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Change in Cognitive Function",
        "description": "Cognitive performance will be assessed using a standardized neuropsychological test battery evaluating memory, attention, and executive function. Scores will be compared from baseline to the end of the intervention period.",
        "timeFrame": "12 weeks"
      }
    ],
    "secondary": [
      {
        "measure": "Change in Functional Capacity (Sit-to-Stand Test)",
        "description": "Functional capacity will be measured by the 30-second sit-to-stand test. The number of repetitions completed will be compared between baseline and study completion.",
        "timeFrame": "12 weeks"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 0,
      "exclusionCount": 0,
      "totalCount": 0
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 40,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T05:06:11.774Z",
  "dataSource": "ClinicalTrials.gov API v2 - Ultimate Complete Collection"
}